Eye drop pro­duc­er KC Phar­ma­ceu­ti­cals re­ceives FDA warn­ing let­ter

The FDA sent a warn­ing let­ter to Cal­i­for­nia-based eye drop man­u­fac­tur­er KC Phar­ma­ceu­ti­cals cit­ing sev­er­al is­sues re­lat­ed to the com­pa­ny’s qual­i­ty sys­tem.

In the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.